Pheochromocytomas: Can malignant potential be predicted?

Urology

Volumn 53, Issue 4, 1999, Pages 679-683

  John, Hubert ^a   Ziegler, Walter H ^a   Hauri, Dieter ^a   Jaeger, Peter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CATECHOLAMINE URINE LEVEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SYMPTOMATOLOGY; TUMOR LOCALIZATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PROGNOSIS;

EID: 0033118548     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00612-8     Document Type: Article

References (20)

1. Lack EE: Adrenal medullary hyperplasia and pheochromocytoma, in: Lack EE (Eds): Pathology of Adrenal and Extra-adrenal Paraganglia. Major Problems in Pathology. Philadelphia, WB Saunders, 1994, vol 29, pp 220-272.
2. Linnoila RI, Keiser HR, Steinberg SM, et al: Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21: 1168-1180, 1990.
3. Venkata C, Ram S, and Fierro-Carrion GA: Pheochromocytoma. Semin Nephrol 15: 126-137, 1995.
4. Ziegler WH: Diagnostik des Phäochromocytoms, in Hauri D, and Schmucki O (Eds): Erkrankungen der Nebenschilddrüsen und Nebennieren. Stuttgart, Gustav Fischer Verlag, 1985, pp 208-216.
5. Saegesser F: Cesar Roux (1857-1934) et son époque. Rev Med Suisse Romande 104: 403-454, 1984.
6. Mayo CH: Paroxysmal hypertension with tumor of retroperitoneal nerve. JAMA 89: 403-454, 1927.
7. Crout JR, Pisano JJ, and Sjoerdsma A: Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Am Heart J 61: 375-381, 1961.
8. Ziegler WH, Labhart A, and Frick P: Schockverhütung beim Phäochromozytom durch präoperative Behandlung mit einem Alpha-Rezeptorenblocker. Bibl Cardiol (Basel) 17: 1-9, 1965.
9. Doppman JL, Reinig JW, Dwyer AJ, et al: Differentiation of adrenal masses by magnetic resonance imaging. Surgery 101: 1018-1026, 1987.
10. Van Gils A, Falke T, van Erkel A, et al: MR Imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographies 11: 37-57, 1991.
11. Mayor G: Die Chirurgie der Nebennieren. Berlin, Springer, 1984.
12. Stoker ME, Patwardhan N, and Maini BS: Laparoscopic adrenal surgery. Surg Endosc 9: 387-391, 1995.
13. Janetschek G, Finkenstedt G, Gasser R, et al: Laparo-scopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 160: 330-334, 1998.
14. Nativ O, Grant CS, Sheps SG, et al: The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer 69: 2683-2687, 1992.
15. Lai MK, Sun CF, Chen CS, et al: Deoxyribonucleic acid flow cytometric study in pheochromocytomas or paragangliomas and its correlation with clinical parameters. Urology 44: 185-188, 1994.
16. Heaney AP, O'Rourke D, Arthur K, et al: Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma. Clin Endocrinol 44: 233-238, 1996.
17. Bravo EL: Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15: 356-368, 1994.
18. Krempf M, Lumbroso J, and Mornex R: Use of m-[131-I]-iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 72: 455-461, 1991.
19. Lewington VJ, Zivanovic MA, Tristam M, et al: Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant pheochromocytoma. J Nucl Biol Med 35: 280-283, 1991.
20. Averbuch SD, Steackley CS, Young RC, et al: Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarabazine. Ann Intern Med 109: 267-273, 1988.